SchillevoortIde BoerAHeringsRMCRoosRACJansenPAFLeufkensHGM. Risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine. Ann Pharmacother2001;35: 1517–22.
2.
SangerDJPerraultG. Effects of typical and atypical antipsychotic drugs on response decrement patterns in rats. J Pharmacol Exp Ther1995;272: 708–13.
3.
BrownCSMarkowitzJSMooreTRParkerNG. Atypical antipsychotics: Part II: Adverse effects, drug interactions, and costs. Ann Pharmacother1999;33: 210–7.
4.
FardeLNordstromALWieselFAPauliSHalldinCSedvallG. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine: Relation to extrapyramidal side effects. Arch Gen Psychiatry1992;49: 538–44.
5.
KapurSZipurskyRRoyPJonesCRemingtonGReedKThe relationship between D2 receptor occupancy and plasma levels on low dose oral haloperidol: A PET study. Psychopharmacology1997;131: 148–52.
6.
KapurSZipurskyRRemingtonG. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. Am J Psychiatry1999;156: 286–93.
7.
DeutchAYMoghaddamBInnisRBKrystalJHAghajanianGKBunneyBSMechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia. Schizophr Res1991;4: 121–56.
8.
KerwinRW. The new atypical antipsychotics: A lack of extra-pyramidal side-effects and new routes of schizophrenia research. Br J Psychiatry1994;164: 141–8.
9.
KinonBJLiebermanJA. Mechanisms of action of atypical antipsychotic drugs: A critical analysis. Psychopharmacology (Berl)1996;124: 2–34.
10.
MeltzerHYMatsubaraSLeeJC. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D1, D2 and serotonin2 pKi values. J Pharmacol Exp Ther1989;251: 238–46.
11.
LahtiRAEvansDLStratmanNCFigurLM. Dopamine D4 versus D2 receptor selectivity of dopamine receptor antagonists: Possible therapeutic implications. Eur J Pharmacol1993;236: 483–6.
12.
KapurSSeemanP. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis. Am J Psychiatry2001;158: 360–9.
